title: Words of wisdom. Re: Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
authors.affiliation: Department of Urology, Kantonsspital, St. Gallen, Switzerland. hans-peter.schmid@kssg.ch
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Schmid
authors.forename: Robert
authors.initials: R
authors.lastname: Theiler